W81K0223F0050↗

Name: W81K0223F0050: Fentanyl/Norfentanyl Immunoassay Reagents for Tripler Army Medical Center, Hawaii
Creator: SpendQuery

FENTANYL/NORFENTANYL IMMUNOASSAY REAGENTS FOR TRIPLER ARMY MEDICAL CENTER, HAWAII

Delivery Order · Department of the Army · to Alere San Diego, Inc. (UEI TWMQTHHN6HM5) · data as of 2026-09-30

Obligated to date$341.8K1 action

Current value$341.8Kwith options exercised

Period2023-04-18 → 2023-05-30current end date

What it is

Product or service: In Vitro Diagnostic Substances, Reagents, Test Kits and Sets (PSC 6550)
Industry: In-Vitro Diagnostic Substance Manufacturing (NAICS 325413)
Contracting office: W40M Mrco Pacific (W81K02)
Competition: Not competed under simplified acquisition
Pricing: Firm fixed price
How it was bought: Single-award IDIQ · under N6264523D5004
Where the work is: San Diego, CA · district CA-51
Topics: opioids

Obligations by fiscal year

FY2023$341.8K

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

1 action since 2023-04-17. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2023-04-17	0		$341.8K	FENTANYL/NORFENTANYL IMMUNOASSAY REAGENTS FOR TRIPLER ARMY MEDICAL CENTER, HAWAII

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-09-30). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗